Articles

MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK;Centre for Haematology, Imperial College London, London, UK
Centre for Haematology, Imperial College London, London, UK
Centre for Haematology, Imperial College London, London, UK
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK;Centre for Haematology, Imperial College London, London, UK
Institute of Hematology, Davidoff Cancer Centre, Beilinson Hospital, Rabin Medical Centre, Petah-Tiqva, Israel
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK
Centre for Haematology, Imperial College London, London, UK
Centre for Haematology, Imperial College London, London, UK
Centre for Haematology, Imperial College London, London, UK
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK;Centre for Haematology, Imperial College London, London, UK
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK
Vol. 104 No. 11 (2019): November, 2019 https://doi.org/10.3324/haematol.2018.214809